Yingxia Li

678 total citations
33 papers, 488 citations indexed

About

Yingxia Li is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingxia Li has authored 33 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingxia Li's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Yeasts and Rust Fungi Studies (2 papers). Yingxia Li is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Yeasts and Rust Fungi Studies (2 papers). Yingxia Li collaborates with scholars based in China, United States and Australia. Yingxia Li's co-authors include Haiying Cheng, Timothy Q. Duong, Libin Jiang, Yixin He, David E. Cohen, Shuai Lv, Dapeng Wei, Qifa Li, Yang Zhou and Hua Luo and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and NeuroImage.

In The Last Decade

Yingxia Li

31 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingxia Li China 13 243 97 65 63 50 33 488
Yuanyuan Sun China 14 150 0.6× 67 0.7× 63 1.0× 39 0.6× 17 0.3× 28 479
Vincent H.S. Chang Taiwan 13 227 0.9× 48 0.5× 72 1.1× 36 0.6× 33 0.7× 25 406
Zhenzhen Liang China 14 228 0.9× 136 1.4× 54 0.8× 50 0.8× 117 2.3× 45 521
Yue Yin China 18 292 1.2× 181 1.9× 150 2.3× 94 1.5× 74 1.5× 48 816
Ding Sun China 13 260 1.1× 174 1.8× 54 0.8× 46 0.7× 47 0.9× 33 491
Jutamas Suwanpradid United States 15 180 0.7× 19 0.2× 46 0.7× 62 1.0× 24 0.5× 18 555
Antonella Vardeu United Kingdom 8 134 0.6× 44 0.5× 112 1.7× 43 0.7× 23 0.5× 11 427
Aftab Taiyab Canada 11 337 1.4× 39 0.4× 45 0.7× 49 0.8× 23 0.5× 21 476

Countries citing papers authored by Yingxia Li

Since Specialization
Citations

This map shows the geographic impact of Yingxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxia Li more than expected).

Fields of papers citing papers by Yingxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxia Li. The network helps show where Yingxia Li may publish in the future.

Co-authorship network of co-authors of Yingxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingxia Li. A scholar is included among the top collaborators of Yingxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingxia Li. Yingxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yingxia, et al.. (2024). Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation. IUBMB Life. 76(10). 845–857.
3.
Li, Yingxia, et al.. (2024). CircEYA3 aggravates intervertebral disc degeneration through the miR-196a-5p/EBF1 axis and NF-κB signaling. Communications Biology. 7(1). 390–390. 2 indexed citations
4.
Li, Yingxia, Ning Dong, Kun Wang, et al.. (2023). 5-HMF attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis mice by inhibiting the MIF-CD74 interaction. Acta Biochimica et Biophysica Sinica. 55(8). 1222–1233. 9 indexed citations
5.
He, Yulong, Shunyi Li, Yueyue Zhu, et al.. (2023). Optimization of potent, selective and orally bioavailable biphenyl scaffold as FABP4 inhibitors for anti-inflammation. European Journal of Medicinal Chemistry. 253. 115319–115319. 4 indexed citations
6.
Zhao, Tianming, Gabriella Bulloch, Lihua Liu, et al.. (2022). Providing HIV testing in men who have sex with men through a gay social networking app in China: A qualitative interview study with multisectoral service providers. Frontiers in Public Health. 10. 1056720–1056720. 5 indexed citations
7.
Li, Yingxia, et al.. (2022). Differences in gastric microbiota and mucosal function between patients with chronic superficial gastritis and intestinal metaplasia. Frontiers in Microbiology. 13. 950325–950325. 4 indexed citations
8.
Chen, Mengting, et al.. (2021). Combined treatment with FABP4 inhibitor ameliorates rosiglitazone‐induced liver steatosis in obese diabetic db/db mice. Basic & Clinical Pharmacology & Toxicology. 129(3). 173–182. 8 indexed citations
9.
Ning, Hanbing, Wenquan Lu, Jingyun Wang, et al.. (2020). Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells. Investigational New Drugs. 39(2). 386–393. 7 indexed citations
10.
Lv, Shuai, et al.. (2020). Mesenchymal epithelial transition factor regulates tumor necrosis factor-related apoptotic induction ligand resistance in hepatocellular carcinoma cells through down-regulation of cyclin B1. The International Journal of Biochemistry & Cell Biology. 128. 105844–105844. 3 indexed citations
12.
Li, Yingxia, et al.. (2019). Down-regulated miR-374c and Hsp70 promote Th17 cell differentiation by inducing Fas expression in experimental autoimmune encephalomyelitis. International Journal of Biological Macromolecules. 154. 1158–1165. 6 indexed citations
13.
Li, Yingxia, et al.. (2019). E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma. Life Sciences. 232. 116649–116649. 22 indexed citations
15.
He, Chi, et al.. (2019). Effectiveness of electroacupuncture for pain after osteosarcoma post surgery. Medicine. 98(44). e17381–e17381. 1 indexed citations
16.
Malana, Geraldine E., Janis Stoll, Anal Desai, et al.. (2013). Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization. PLoS ONE. 8(3). e58084–e58084. 69 indexed citations
17.
Hui, Feng-Li, Qiuhong Niu, Tao Ke, Yingxia Li, & Ching-Fu Lee. (2012). Candida sanyaensis sp. nov., an ascomycetous yeast species isolated from soil. Antonie van Leeuwenhoek. 103(1). 47–52. 9 indexed citations
18.
Hui, Feng-Li, Qiuhong Niu, Tao Ke, & Yingxia Li. (2012). Cryptococcus nanyangensis sp. nov., A New Basidiomycetous Yeast Isolated from the Gut of Wood-Boring Larvae. Current Microbiology. 65(5). 617–621. 3 indexed citations
19.
Sun, Yuan, et al.. (2011). Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells. Journal of Cancer. 2. 36–51. 20 indexed citations
20.
Li, Yingxia, Haiying Cheng, & Timothy Q. Duong. (2007). Blood-flow magnetic resonance imaging of the retina. NeuroImage. 39(4). 1744–1751. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026